Resources

We explore individual-level, network-level, and community-level characteristics associated with MOUD uptake in young people who inject drugs and their support network members.

The objective of our study was to explore mental health clinician attitudes towards substance use and associations with clinical experience and education level

In examining past policies, practices, and discourse that support heroin regulation and drug prohibition, the drivers of the current illegal drug overdose death epidemic in Canada are brought more

We explored the likelihood of securing a new primary care provider (PCP) among people with varying histories of opioid use who had recently lost access to their PCP.

This article examines how clinics’ take-home dosing policies have affected patients’ experiences of treatment and lives in general.

This study evaluated how telemedicine as a modality for opioid agonist treatment compares to in-person care

To investigate excess costs of buprenorphine-naloxone due to unmerited market exclusivity (no legal patent or data protection) in Canada.

We explored perspectives of people who use drugs (PWUD) on the changing drug supply in Oregon, experiences of and response to fentanyl-involved overdose, and recommendations from PWUD to reduce ove

To assess for long-term positive effects of buprenorphine treatment (BT) on opioid use disorder (OUD) at a Nishnawbe Aski Nation high school clinic

Collecting in-person UDS may not always be feasible, contributing to the need to understand factors that influence the validity of self-reported substance use.

Traditionally, “success” in MOUD treatment is measured in terms of program retention, adherence to MOUD, and abstinence from opioid and other drug use.

Drawing on data from U.S.

This study identified patient profiles in terms of their quality of outpatient care use, associated sociodemographic and clinical characteristics, and adverse outcomes based on frequent emergency d

This study estimated cost savings from expanding access to substance use disorder (SUD) treatment for persons with opioid use disorders (OUD).

The aim of this study was to examine what drives increases in opioid overdose death among Black Americans based on the experience of key stakeholders.

Take-Home Naloxone (THN) kits may be stored in non-standard conditions, including in vehicles, backpacks, and out of doors.

This paper builds upon the concept of the ‘informed patient’ to explore individuals’ decisions to initiate injectable depot buprenorphine.